https://t.co/Cn6rIHopEp

Where are with PI3K inhibitors and what more do we need to do. Watch and read all about it here. @CarlosArteagaMD @SusanGKomen @MSKCancerCenter @tperrybrown @OncoAlert #bcsm

Join us for SABCS Salutes Patients and Survivors. This inaugural event—held in conjunction with #SABCS25 (Mon, Dec 8, 2:30-4:00 PM)—will promote long-term health and enhanced quality of life by celebrating survivorship and providing educational resources. https://t.co/oxLl0FyCLB

Must read from NBCC President Fran Visco: Cutting federal funding for research on mRNA vaccine technology will set back promising efforts to prevent and treat breast cancer. https://t.co/tmDOoSpthG

Event Spotlight: At a recent NBCC webinar, Dr. Sarah Lima made a compelling case that breast cancer outcomes cannot be fully understood—or addressed—without grappling with the legacy of structural racism and disinvestment. Read our recap:

Every cancer patient deserves a complete diagnosis.

About 1 in 3 cancers later come back. Lewis Chodosh, MD, PhD, and Angela DeMichele, MD, MSCE, are bringing the “sleeper” phase of cancer to light—and offering hope that future treatments can stop cancer from reawakening. https://t.co/Q6MwKsZN4x

Cancer fatigue isn’t just tiredness, and it can’t be fixed by sleeping more (though that can help). Cancer fatigue is physical, emotional, and mental. https://t.co/MuCRUj2yvz #bcsm #CancerFatigue #DCIS

A nice patient friendly article on how metastases occur in breast cancer and how cells adapt to their metastatic environment. #bcsm https://t.co/XqzBo8TYoP

Join UNC's Asst. Professor of Medicine and Breast Cancer Clinical Trial Program Leader Yara Abdou, MD on 6/12 as she discusses racial inequities and HER2-Negative breast cancer.This group will fill up fast, so make sure you register today. https://t.co/84zhbuz67h #asco #GRASP

Thanks @SusanGKomen for the opportunity to be a part of this discussion.

Black in Blues book tour 🩵

What happened in breast cancer in 2024? A summary of important studies👇 #bcsm

Check out this recent article discussing further optimizing care of patients with operable hormone receptor-sensitive #BreastCancer 👉 https://t.co/R6k567CyeE @A_THOMASMD @elmayermd @Prof_Nadia_H @curijoey @MIgnatiadis @virologyst @tperrybrown @KalinskyKevin @awolff

https://t.co/hyv3FdlOxm

Dr. @innodim Opara gave a whole sermon on "Navigating the Socio-Political Climate for Communities, Science and Healthcare" at the @ONealCancerUAB UAB O'Neal Comprehensive Cancer Center's #Learningd Conference!

Friends applauds the recent @FDA DAP guidance. We appreciate the FDA's ongoing efforts to ensure that #clinicaltrials are inclusive and representative and look forward to continued collaboration to achieve these goals. Read our public comment here: https://t.co/oe2NwrzMMk

FDA Approves Ribociclib With an Aromatase Inhibitor in Early Breast Cancer. This is for stage 2 and 3 breast cancer at high risk for recurrence, that includes node negative disease. #bcsm ⁦@OncoAlert⁩

Katia Khoury gives a beautiful presentation of Dato-DXd x 4 cycles in the ISPY2.2 trial. Exciting data minimizing chemo and tox in a subset of pts with very high risk disease. #ESMO24 @OncoAlert

Our feedback and interactions with researchers makes a difference. Your participation in this study can also make a difference — calling all women with metastatic breast cancer! Participate now by completing this brief online survey: https://t.co/lMVByKvf0V

"A vote is a kind of prayer for the kind of world we desire for ourselves and for our children, and we are stronger when we pray together." ~@ReverendWarnock